Xoma | XOMA - Ebitda





Ebitda Changement Date
AbbVie USD 5.37B 1.85B 2025-12
Agenus USD -10.11M 19.02M 2025-03
Agios Pharmaceuticals USD -120.31M 4.82M 2025-12
Ardelyx USD 6.02M 447K 2025-12
aTyr Pharma USD 25.85M 52.43M 2025-12
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Celldex Therapeutics USD -86.34M 13.54M 2025-12
Curis USD -12.3M 231K 2023-09
Eli Lilly USD 12.14B 4.26B 2025-12
Incyte USD 367.97M 46.53M 2026-03
MacroGenics USD 21.95M 55.39M 2025-09
Novartis USD 5.3B 530M 2026-03
Novartis USD 5.84B 235M 2025-09
Pfizer USD 756M 5.32B 2025-12
Prothena USD -39.53M 12.25M 2025-09
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Xoma USD 2.52M 7.98M 2024-06